As a diabetes medication, GLP-1s are able to treat insulin resistance, something that many people with PCOS deal with. “It’s ...

What goes up can come down. Investors who jumped on the Hims & Hers Health (NYSE: HIMS) bandwagon have experienced this pain ...

Read all the latest news headline updates on weight loss. Get all the weight loss breaking news updates, videos, photostories and more at Business Standard.

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents. The knockoff surge was led by Hims & Hers Health, the telehealth firm ...

How you add protein to the diet decides how quickly you lose weight without affecting health. Protein plays a crucial role in weight loss by promoting satiety, preserving muscle mass, and boosting ...

Mark Millich, 26 years old and insecure about his thinning hair, was curious about the ads he saw promising to reverse his hair loss. He completed a 14-question intake on Hims.com and received a ...

Introducing Hot Shots, a series that examines how Ozempic and other GLP-1 drugs have transformed the way we think about our bodies, weight loss ... retailers such as Hers or WeightWatchers ...

including for weight loss, anxiety, libido, hair loss and skincare. Hims & Hers reported a nearly $1.5 billion profit in 2024, a 69% increase year over year. Non-GLP-1 offerings grew 43% year over ...

Drugs like Ozempic have a positive impact on weight loss, though only for a short period, with long-term health implications of a growing concern, the business said. GLP-1 drugs can also erode muscle ...

Hims & Hers is shutting down the dermatology ... The company had a strong 2024, buoyed by the growth of its weight-loss business. Its revenue jumped 69% to $1.48 billion, with its GLP-1 offering ...